ARTICLES LIST

 

Total Results: 16203

Media ID Source Name Media Type Language Media Name Media Description Keywords Keywords Link to Article
1557 National Cancer Institute Html en Colorectal Cancer Screening (PDQ®)–Patient Version There are five types of tests that are used to screen for colorectal cancer: fecal occult blood test, sigmoidoscopy, colonoscopy, virtual colonoscopy, and DNA stool test. Learn more about these and other tests in this expert-reviewed summary.
PDQ Screening0.618949
stool0.590523
cancer treatment0.582023
digital rectal exam0.64051
ongoing clinical trials0.583111
screening tests0.63308
Different screening tests0.618821
abnormal areas0.580093
following PDQ summaries0.632044
Cancer Information Service0.620236
PDQ cancer information0.80153
false-negative test result0.583041
Colorectal Cancer Prevention0.669028
positive test result0.639633
Prevention Editorial Board0.62622
treatment clinical trials0.578891
National Cancer Institute0.708875
clinical trials0.776593
colorectal cancer screening0.731391
PDQ documents0.584043
tube-like instrument0.57905
test result0.671884
cancer information summary0.700249
clinical trial0.586822
new treatment0.582243
breast cancer prevention0.604538
colorectal cancer0.988753
Cancer screening trials0.664201
false-positive test result0.582754
new colorectal cancer0.672245
colon cancer0.621374
colorectal cancer help0.669499
fecal immunochemical test0.586261
Cancer Care page0.608301
PDQ database0.587115
latest published information0.582352
NCI’s PDQ0.590817
virtual colonoscopy0.681415
PDQ summary0.644281
cancer symptoms0.598532
NCI PDQ cancer0.66186
tests0.64391
cancer information summaries0.626981
special card0.600211
comprehensive cancer information0.626204
occult blood test0.58711
rectum0.607195
CLICK HERE
1624 National Cancer Institute Html en Wilms Tumor and Other Childhood Kidney Tumors Treatment (PDQ®)–Patient Version Expert-reviewed information summary about the treatment of Wilms tumor.
wilms tumor0.926034
treatment0.447725
malignant tumor cells0.243725
cancer treatment0.217156
abdomen0.245624
NCI-supported cancer0.203382
cancer cells0.312954
body0.284934
type0.202622
chemotherapy0.265514
kidney0.420084
clinical trial search0.271589
PDQ Wilms Tumor0.212419
clinical trials0.537885
Wilms tumor spreads0.21053
Wilms tumor depend0.213963
clinical trial0.332838
renal cell cancer0.378864
combination chemotherapy0.254074
blood0.211019
PDQ summary0.204133
metastatic Wilms tumor0.210734
cancer clinical trials0.268102
lymph nodes0.354558
congenital mesoblastic nephroma0.200441
anaplastic Wilms tumor0.26619
radiation therapy0.416592
rhabdoid tumor0.263616
cancer0.757965
information0.244245
Wilms tumor cells0.224035
childhood kidney tumors0.354935
CLICK HERE
1654 National Cancer Institute Html en Gerson Therapy (PDQ®)–Health Professional Version Expert-reviewed information summary about Gerson therapy as a treatment for people with cancer. Note: The information in this summary is no longer being updated and is provided for reference purposes only.
complex regimen0.484073
prescribed conventional regimen0.48627
body0.480118
treatment regimen0.476762
New York City0.503592
American Cancer Society0.4659
normal metabolic state0.454242
Gerson’s data0.572285
coffee enemas0.55048
Gerson Research Organization0.580725
cancer information summary0.482421
cancer therapies0.454018
colorectal cancer0.455812
diet regimen0.532413
Gerson therapy0.918805
patients0.555703
cancer patients0.512802
Gerson’s life0.570445
Gerson regimen0.719238
flaxseed oil0.455436
diet group0.469079
Charlotte Gerson Straus0.587654
injectable crude liver0.462964
gonzalez regimen0.487953
potassium0.46778
United States0.4578
Gerson approach0.560315
cancer cells0.467412
5-year survival rate0.480223
cancer cell biology0.469353
Gerson regimen.0.568736
A. Pancreatic enzymes0.456434
potassium solution0.46218
excess sodium0.454821
Gerson Hospital0.567697
Gerson approach.0.560098
National Cancer Institute0.466567
Desiccated liver capsules0.461935
stage I–II patients0.465698
New York0.508367
Gerson segment0.563678
pancreatic enzymes0.529579
Gerson Institute0.579619
healthy liver function.0.462886
Gerson diet0.622931
crude liver extract0.544679
melanoma patients0.45525
cancer0.570183
Max Gerson0.650691
CLICK HERE
1697 National Cancer Institute Html en High-Dose Vitamin C (PDQ®)–Patient Version Expert-reviewed information summary about the use of high-dose vitamin C as a treatment for people with cancer.
cancer treatment0.409014
Vitamin C levels0.46062
chemotherapy0.385658
PDQ cancer information0.495143
Cancer Complementary0.400016
vitamin C therapy0.473688
vitamin C. Patients0.500759
vitamin C. Studies0.500091
clinical trials0.625144
cancer information summary0.452988
laboratory studies0.446817
alternative cancer therapies0.39781
clinical trial0.386901
high doses0.433559
prostate cancer cells0.388026
CAM cancer research0.38618
ovarian cancer0.395778
malignant mesothelioma0.387621
High-Dose Vitamin C.0.544572
patients0.543391
cancer patients0.435773
NCI PDQ cancer0.414799
cancer information database0.396035
effects0.387385
Therapies Editorial Board0.399092
cancer information0.505736
treatment0.52957
breast cancer cells0.389833
intravenous high-dose vitamin0.577226
Complementary Therapies Editorial0.414088
Drug Administration0.422556
Cancer Information Specialist0.391085
dehydroascorbic acid0.390795
cancer cells0.552348
Cancer Information Service0.451182
anticancer drugs0.396426
high-dose ascorbic acid0.545315
National Cancer Institute0.563244
alternative medicine0.442263
health care0.392613
advanced pancreatic cancer0.416341
high-dose IV vitamin0.624976
vitamin C treatment0.515175
breast cancer0.420605
animal studies0.461706
alternative therapies0.414436
high-dose vitamin0.916436
cancer information summaries0.396462
CLICK HERE
1794 National Cancer Institute Html es El dolor y el cáncer (PDQ®)–Versión para pacientes Resumen de información revisada por expertos acerca del dolor como una complicación a causa del cáncer o su tratamiento. Se tratan abordajes para el control y el tratamiento del dolor relacionado con el cáncer.
PDQ Complicaciones0.575413
edad avanzada.Dosis0.516499
Physician Data Query0.512343
Estados Unidos0.550291
radioterapia ayuda0.539968
siguientes tipos0.59269
libre uso0.498177
vía oral0.816108
¿El dolor0.996907
largo plazo0.526626
siguientes observaciones0.519179
Cancer Institute0.496567
siguientes exámenes0.600861
pacientes quizás0.564494
familia instrucciones0.559775
síndrome mano-pie0.573945
siguientes medicamentos0.524062
siguientes momentos0.614035
empeoramiento pasajero0.644072
siguientes sumarios0.581267
PDQ Acupuntura0.539252
vía iv0.553442
Institutos Nacionales0.504308
CLICK HERE
1873 National Cancer Institute Html es Tratamiento del sarcoma uterino (PDQ®)–Versión para profesionales de salud Resumen de información revisada por expertos acerca del tratamiento del sarcoma uterino.
Obstet Gynecol0.426292
Major FJ0.422403
sarcomas uterinos0.471793
cisplatin as0.411109
Markman M0.40448
gynecologic cancer0.405911
prognostic factors0.405684
Brunetto VL0.40512
Sin embargo0.405423
or without paclitaxel0.411277
fase ii0.413551
Ifosfamide treatment0.404047
endometrial stromal sarcoma0.415162
Radiat Oncol Biol0.40725
siguientes puntos0.405418
oncology group study0.684258
stromal sarcomas previously0.409618
patología equivocada0.404764
Barrett RJ0.404588
Kilgore L0.404374
recurrent or metastatic0.405758
mixed mesodermal tumors0.448955
Gynecologic Oncology Group0.969258
Gynecol Oncol0.445429
Filiaci V0.404525
Beecham J0.404572
or recurrent leiomyosarcoma0.405872
Blessing JA0.5678
meses vs0.434084
Organización Mundial0.408363
pilot study0.40409
sarcomas mesodérmicos mixtos0.406902
Smith MR0.405644
as second-line chemotherapy0.406079
or recurrent0.412147
New York0.404218
Peters WA0.405698
Clin Oncol0.49692
combination chemotherapy0.409211
verdaderos sarcomas0.414072
Oncol Biol Phys0.407314
cuerpo uterino0.408492
elementos homólogos0.406306
estadio iii0.405213
Rosenshein N0.4046
stromal sarcoma0.431127
Homesley HD0.404643
dimethyl triazenoimidazole carboxamide0.404595
with or without0.432244
CLICK HERE
1895 National Cancer Institute Html null Tratamiento del cáncer de pulmón de células pequeñas (PDQ®)–Versión para pacientes Resumen de información revisada por expertos acerca del tratamiento del cáncer de pulmón de células pequeñas.
CLICK HERE
2001 National Cancer Institute Html es Familiares a cargo de pacientes de cáncer: funciones y desafíos (PDQ®)–Versión para profesionales de salud Sumario informativo revisado por expertos acerca de los desafíos que enfrentan los familiares a cargo de los pacientes con cáncer. Este resumen se centra en las funciones típicas y las inquietudes de las personas a cargo del paciente y en las intervenciones útiles para esas personas.
etapa final0.435131
Cancer Communication Assessment0.482566
giving bad news0.42261
to breast0.424042
Sin embargo0.471583
receiving palliative care0.419812
American Cancer Society0.47018
Family support0.41866
family to breast0.421621
CA Cancer0.459636
Given BA0.442227
Communication Assessment Tool0.434693
Rose JH0.438883
family meetings0.426208
Estados Unidos0.421866
Support Care0.447919
Caregivers Based0.422755
Palliat Care0.44789
patients with0.44256
Pain Symptom Manage0.455568
Support Oncol0.41857
Baile WF0.422726
Family Caregiver Support0.426151
family caregivers0.94013
Crit Care Nurs0.421936
Oncol Nurs Forum0.49008
with family caregivers0.435774
Care Cancer0.474055
Cancer Facts0.43863
Arnold RM0.422137
palliative care0.565514
Hosp Palliat Care0.420581
paciente cumpla0.459325
terminally ill patients0.428058
Family caregiver quality0.42241
communication skills0.434733
cancer pain0.552042
Crit Care0.427432
Palliat Med0.438559
Given CW0.427811
breast cancer0.524972
Arch Intern Med0.454734
Conducting family meetings0.417671
Baider L0.421555
caregivers with0.421979
placing family meetings0.417694
Crit Care Med0.422158
symptoms among caregivers0.425057
cancer communication0.540368
CLICK HERE
2038 National Cancer Institute Html es Prevención del cáncer de piel (PDQ®)–Versión para pacientes Sumario de información revisada por expertos sobre factores que pueden influir en el riesgo de presentar cáncer de piel y sobre las investigaciones dirigidas a prevenir esta enfermedad.
nevo atípico0.426748
almacena agua0.428194
voluntarios sanos0.420911
filtros solares0.422801
ropa protectora0.423732
menor exposición0.423337
protector solar0.980296
protector solar ayuda0.457908
siguientes ejemplos0.47268
luz solar0.660447
vitamina d0.429105
National Cancer Institute0.427791
piel melanoma0.815892
Instituto Nacional0.448341
lunares benignos0.424057
antecedentes familiares0.421492
lámparas solares0.426025
suficientes estudios0.422469
Physician Data Query0.500422
radiación uv0.839863
Estados Unidos0.55931
vitamina b30.46569
suficiente ejercicio0.427407
prevención revisa0.424823
PDQ Prevención0.445149
siguientes sustancias0.424243
radiación ultravioleta0.557367
siguientes sumarios0.449523
CLICK HERE
15635 National Cancer Institute Html en Step 4: Award Negotiation & Issuance Before a grant can be awarded and accepted, several pre-award activities must happen to formalize the partnership. Ensuring compliance with federal laws, a review of costs and a negotiation of the appropriate funding level must all happen in order to rece
applicant institution0.49498
NoA0.545113
NIH eRA Commons0.538439
HHS requirements0.455116
applicant’s business0.43403
special terms0.42079
business/administrative management perspective0.537644
initial budget period0.503089
grants management specialist0.84443
subsequent budget periods0.62245
NIH official0.455564
multiple pre-award activities0.51965
award0.677162
post-award process0.430443
Grants Administration staff0.556889
pre-award process0.432795
terms0.443034
Noncompeting Award Process0.543798
special conditions0.423887
new recipient requirements0.531908
research staff0.423565
Associated F&A costs0.474288
HHS Congressional Liaison0.509654
grants management0.935861
NIH Grants Policy0.596078
specialized terms0.42458
grants specialist0.462503
categorical budget0.451864
NCI staff0.518462
award information0.450047
management officer certifies0.491818
awarding office0.423573
HHS Payment Management0.546384
NIH GPS0.461713
overall scientific endeavor0.511733
review recommendations0.498295
Initial peer review0.489678
grants management officer0.679819
budget category0.426444
NIH Office0.466998
institute special monitoring0.484399
policy requirements0.426959
appropriate funding level0.509975
pre-award negotiation process0.500978
legally binding requirements0.48831
award notices0.446172
CLICK HERE

 

 

 

Terms of Use | Privacy Policy
©2017 ARCHES Technology. All Rights Reserved.